NextGen Sciences Sells Protein Expression System to GSK | GenomeWeb

NEW YORK, June 10 (GenomeWeb News) - NextGen Sciences has sold a protein expression instrument to GlaxoSmithKline in the UK, the company said today.

 

GSK will use NextGen's Expressionfactory instrument, which automates protein expression and purification, in its gene expression and protein biochemistry department.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.